Dexcom Inc banner

Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 76.65 USD -1.71% Market Closed
Market Cap: $29.6B

Wall St Price Targets

DXCM Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DXCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXCM is 88 USD with a low forecast of 75.75 USD and a high forecast of 117.6 USD.

Lowest Forecast
Price Target
75.75 USD
1% Downside
Average Forecast
Price Target
88 USD
15% Upside
Highest Forecast
Price Target
117.6 USD
53% Upside
Dexcom Inc Competitors:
Price Targets
GWH
ESS Tech Inc
131% Upside
TXN
Texas Instruments Inc
3% Upside
SITM
SiTime Corp
54% Upside
PMVP
PMV Pharmaceuticals Inc
243% Upside

Revenue
Forecast

34% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
34% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.

Gross Profit
Forecast

37% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
37% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 5 years is 14%.

Operating Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

The compound annual growth rate for Operating Income over the next 5 years is 19%.

Pre-Tax Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.

Net Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

The compound annual growth rate for Net Income over the next 5 years is 19%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DXCM's stock price target?
Price Target
88 USD

According to Wall Street analysts, the average 1-year price target for DXCM is 88 USD with a low forecast of 75.75 USD and a high forecast of 117.6 USD.

What is the Revenue forecast for Dexcom Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.

What is the Gross Profit forecast for Dexcom Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 5 years is 14%.

What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Operating Income over the next 5 years is 19%.

What is the Pre-Tax Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.

What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Net Income over the next 5 years is 19%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett